People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cullinan Mica Corp. | — | Pharmaceuticals | Series B | $26.6M | $174.3M | 2022 |
ANTHONY ROSENBERG at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside ANTHONY ROSENBERG on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jay B. Lichter | 1 | 3 |
| Nadim Ahmed | 1 | 3 |
| NEIL W. GIBSON, Ph.D. | 1 | 1 |
| ASHER PAGE | 1 | 1 |
| LEIGH ZAWEL | 1 | 1 |
| Morana B. Jovan-Embiricos | 1 | 1 |
| Anthony B. Rosenberg | 1 | 1 |
| Owen B. Hughes | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.